Cargando…
Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
BACKGROUND: Laser therapy has been the gold standard treatment for retinopathy of prematurity (ROP), while intravitreal bevacizumab (IVB) is reported to be of significant benefit for zone I ROP. A problem with laser therapy is that it is difficult to administer in ROP patients with severely dilated...
Autores principales: | Higashiyama, Tomoaki, Muraki, Sanae, Ohji, Masahito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465726/ https://www.ncbi.nlm.nih.gov/pubmed/28611651 http://dx.doi.org/10.1159/000461575 |
Ejemplares similares
-
Persistent Tunica Vasculosa Lentis in Full-Term Infants: A Report of Two Cases
por: Hamdi, Talaat, et al.
Publicado: (2020) -
Persistent anterior tunica vasculosa lentis in multisystemic smooth muscle dysfunction syndrome: A case report
por: She, Kaiqin, et al.
Publicado: (2021) -
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata, Shumpei, et al.
Publicado: (2019) -
Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021) -
Congenital cataract associated with persistent hyperplastic primary vitreous and persistent tunica vasculosa lentis in a sambar deer (Rusa unicolor) – clinical, ultrasonographic, and histological findings
por: Somma, André Tavares, et al.
Publicado: (2016)